Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously)
1. 系统已在2026-04-29 17:28:20对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
R Ogawa, JM Stachnik, H Echizen
Clinical pharmacokinetics, 2013
Springer
Heart failure is one of the leading causes of death in developed countries, and its prevalence is expected to increase further in the coming years. While the pharmacokinetic changes observed in patients with heart failure have been reviewed twice in Clinical Pharmacokinetics, approximately a quarter century has passed since the latest article was published in 1988. Since then, many important classes of agents (eg ACE inhibitors, angiotensin receptor antagonists and inotropes) have been introduced for the treatment of …
